Catalysts for Strides Pharma Inc
359 tracked
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 22, 2025
approval
MORPHINE SULFATE — FDA approval
Kapanol
→
Nov 24, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 21, 2025
approval
URSODIOL — FDA approval
URSODIOL
→
Oct 21, 2025
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Sep 30, 2025
approval
PREGABALIN — FDA approval
PREGABALIN
→
Sep 16, 2025
approval
ACETAZOLAMIDE — FDA approval
ACETAZOLAMIDE
→
Aug 6, 2025
recall
Strides Pharma, Inc. recall (Cls II)
Strides Pharma Inc
→
Jul 21, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 2, 2025
recall
Strides Pharma, Inc. recall (Cls II)
Strides Pharma Inc
→
Apr 2, 2025
recall
Strides Pharma, Inc. recall (Cls II)
Strides Pharma Inc
→
Mar 31, 2025
approval
DOXYCYCLINE HYCLATE — FDA approval
DOXYCYCLINE HYCLATE
→
Mar 28, 2025
approval
ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Mar 28, 2025
approval
ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Mar 27, 2025
approval
DOXYCYCLINE HYCLATE — FDA approval
DOXYCYCLINE HYCLATE
→
Mar 27, 2025
approval
DOXYCYCLINE HYCLATE — FDA approval
DOXYCYCLINE HYCLATE
→
Mar 27, 2025
approval
DOXYCYCLINE HYCLATE — FDA approval
DOXYCYCLINE HYCLATE
→
Mar 10, 2025
approval
ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Mar 5, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Feb 4, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 4, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 9, 2024
approval
PREGABALIN — FDA approval
PREGABALIN
→
Nov 21, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
Strides Pharma Inc
→
Nov 21, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
Strides Pharma Inc
→
Nov 21, 2024
approval
HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE) — FDA approval
Strides Pharma Inc
→